Market Overview

Not Too Late to Buy Baxter, Jim Cramer Says

Share:
Related BAX
Earnings Scheduled For January 29, 2015
Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy
Where To Put My Money: Another Look At My Core Holdings (Seeking Alpha)

Coming out of the Twittersphere late Thursday night: Jim Cramer offers advice to an investor who missed out on scooping up shares of Baxter International (NYSE: BAX) before the company announced a breakup into two separate, independent global healthcare companies.

Cramer, who correctly predicted Baxter's breakup, believes the stock can still be bought.

Shares of Baxter opened at $75.68, but closed at $72.80, finishing up 3.8 percent on Thursday.

Posted-In: Jim CramerAnalyst Color Jim Cramer Media Trading Ideas

 

Related Articles (BAX)

Around the Web, We're Loving...